News
A new global study reveals a striking post-pandemic surge in gut-brain disorders like IBS and functional dyspepsia.
Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis GlobeNewswire, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results